1.Mid-term Clinical & Angiographic Outcomes of Primary Stenting in Acute Myocardial Infarction.
Jei Keon CHAE ; Koang Ho CHOI ; Sung Ki MOON ; Won Ho KIM ; Jae Ki KO
Korean Circulation Journal 1999;29(1):28-35
BACKGROUND AND OBJECTIVES: The goal of this study was to examine the safety and feasibility of a primary (direct) stenting in acute myocardial infarction (AMI). In the treatment of AMI, Percutaneous transluminal coronary angioplasty (PTCA) has documented superior reperfusion rate and improved clinical outcomes than thrombolytic therapy. However, there are several limitations of PTCA, such as recurrent ischemia in 10 to 15%, reinfarction in 3 to 5% and restenosis in 30 to 50% of patients. There are several reports that, compared with PTCA, the implantation of coronary stent has been shown to reduce angiographic restenosis and improve late clinical outcomes. But in general, stenting has been contraindicated in thrombus containing lesion due to the risk of subacute thrombosis. With advance in technique and the recognition of the importance of adequate platelet inhibition, the incidence of subacute thrombosis has fallen in patients with acute coronary syndrome and thrombus laden lesion. Methods and Results: In our study, primary stenting was performed in 42 patients of AMI. There are 6 cases (22.5%) target lesion restenosis during the follow up coronary angiography (150+/-86day) and no in-hospital death. Three cases (7.1%) of them require revascularization including two re-PCTA and a coronary artery bypass graft for the recurrent ischemic symptoms. There were no reinfarction and death after discharge. Six-months event free survival reate was 85.7%. CONCLUSION: Primary stenting is safe and feasible in the majority of patients with AMI and results in excellent mid-term outcomes compared with PTCA.
Acute Coronary Syndrome
;
Angioplasty, Balloon, Coronary
;
Blood Platelets
;
Coronary Angiography
;
Coronary Artery Bypass
;
Disease-Free Survival
;
Follow-Up Studies
;
Humans
;
Incidence
;
Ischemia
;
Myocardial Infarction*
;
Reperfusion
;
Stents*
;
Thrombolytic Therapy
;
Thrombosis
;
Transplants
2.Comedonal Darier's Disease.
Ki Hoon SONG ; Sung Moon JUNG ; Ki Ho KIM ; Gwang Yeol JOH
Annals of Dermatology 1997;9(2):159-162
Darier's disease is a well-known genodermatosis characterized by recurrent waxy, hyperkeratotic papules usually occurring over the seborrheic area. The major histopathological changes are characteristic acantholysis and dyskeratosis which are diagnostic of the disease with typical clinical features. There are less common variants including the hypertrophic, vesicobullous and linear type. However, comedonal lesions are very rare. We report an unusual case of Darier's disease, which showed prominent comedonal papules and plaques over the face, scalp and upper trunk with the typical findings of Darier's disease.
Acantholysis
;
Darier Disease*
;
Scalp
3.A Case of Pheochromocytoma Presented with Acute Myocardial Infarction.
Hyun Sun JEON ; Sung Ki MOON ; Jei Keon CHAE ; Won Ho KIM ; Jae Ki KO
Korean Circulation Journal 1999;29(3):306-310
A 36-year-old woman was presented with extensive anterior wall myocardial infarction. We tried to perform direct coronary angiography for the purpose of primary stenting. However, coronary angiogram revealed normal coronary arteries without intracoronary thrombi. We continued further evaluations to find out the cause of normal coronary myocardial infarction. The findings of severe hypertensive retinopathy and concentric left ventricular hypertrophy suggested that she had secondary hypertension. The detailed history, laboratory and radiological findings revealed the pheochromocytoma. The tumor was successfully removed by operation.
Adult
;
Anterior Wall Myocardial Infarction
;
Coronary Angiography
;
Coronary Vessels
;
Female
;
Humans
;
Hypertension
;
Hypertensive Retinopathy
;
Hypertrophy, Left Ventricular
;
Myocardial Infarction*
;
Pheochromocytoma*
;
Stents
4.Early and Mid-term Results of Coronary Stenting in the Diabetic Patient.
Hyun Sun JEON ; Jei Keon CHAE ; Sung Ki MOON ; Won Ho KIM ; Jae Ki KO
Korean Circulation Journal 1999;29(3):292-297
BACKGROUNG AND OBJECTIVES: Diabetes mellitus is a significant risk factor for adverse outcome after PTCA, which is associated with an increased late mortality and target lesion revascularization (TLR) rates. The beneficial role of coronary stenting on the clinical and angiographic outcomes of diabetic patients is not clearly defined. The aim of this study was to evaluate the early and mid-term outcomes in diabetic patients undergoing elective stenting of native coronary lesions compared with those in non-diabetic patients. MATERIALS AND METHODS: Between July 1997 and June 1998, coronary stenting was performed on 46 lesions in 38 diabetic patients and 126 lesions in 117 non-diabetic patients. Follow-up angiography at mean day of 189+/-45 was performed in 58.7% (91 patients) and analysed by quantitative coronary angiography (QCA). RESULTS: There was a higher incidence of multi-vessel disease in diabetic patients than non-diabetic patients but not statistically significant (71.1% vs 51.3%, p=0.106). There were no differences in major procedural complications and in-hospital events (myocardial infarction, angina and death) in diabetics and non-diabetics. During the follow-up, the incidence of target lesion revascularizton (TLR) and cardiac event free survival did not differ between two groups. CONCLUSION: Coronary stenting in diabetics resulted in a low rate of immediate procedural com-plications and early major adverse cardiac event (MACE), similar to non-diabetics. There were no differences in the mid-term clinical and angiographic outcomes in diabetics and non-diabetics.
Angiography
;
Coronary Angiography
;
Diabetes Mellitus
;
Disease-Free Survival
;
Follow-Up Studies
;
Humans
;
Incidence
;
Infarction
;
Mortality
;
Risk Factors
;
Stents*
5.Clinical and Angiographic Outcomes: Subcutaneous Nadroparin versus Ticlopidine after Coronary Stenting.
Kyoung Deok SHIN ; Jei Keon CHAE ; Sung Ki MOON ; Won Ho KIM ; Jae Ki KO
Korean Circulation Journal 1999;29(3):259-265
BACKGROUNG AND OBJECTIVES: It was reported that low molecular weight heparin (LMWH) was more effective than unfractionated heparin in patients with acute coronary syndrome. Recent studies have shown that the pathophysiology of restenosis in stented lesions was different from those of nonstented lesions. Treatment strategies designed to limit cellular proliferation that were ineffective in nonstented lesions may be efficacious in reducing in-stent restenosis. This study was aimed to compare the clinical and angiographic results of LMWH (nadroparin) after coronary stenting with those of conventional ticlopidine regimen. MATERIALS AND METHODS: Patients were eligible for inclusion if they had angina and/or objective evidence of myocardial ischemia, and a significant (>50%) stenosis that was documented on a recent coronary angiogram. After stenting, prospective randomized comparison study was performed. Patients were randomly assigned to either nadroparin (200 IU/kg, sc, bid) or ticlopidine (250 mg bid) plus aspirin (200 mg qd) treatment groups. Repeat coronary angiography (KERN=*)was performed at 236+/-90days after stenting, and quantitative coronary angiographic analysis (QCA) was done. RESULTS: Intracoronary stent implantation was performed in eighty five lesions in eighty one patients (ticlopidine:40, nadroparin:41). There was no significant difference in any baseline clinical/angiographic variables between the two treatment groups. There were no subacute stent thrombosis, infarction and death in both groups. Six-month event-free survival was 36 (90%) in the ticlopidine group and 35 (85.4%) in the nadroparin group. Follow-up quantitative angiographic data such as late loss (1.35+/-0.70 vs 1.32+/-0.69), loss index (0.53+/-0.70 vs 0.56+/-0.23) and restenosis rate (36% vs 25.8%) were not different between ticlopidine and nadroparin groups. CONCLUSION: Effects of nadroparin were not different from those with ticlopidine therapy in the prevention of restenosis and subacute stent thorombosis after coronary stenting. Clinical outcomes between two strategies were similar. Low molecular weight heparin may be an alternative to ticlopidine in patients that ticlopidine cannot be administered because of severe adverse effects.
Acute Coronary Syndrome
;
Aspirin
;
Cell Proliferation
;
Constriction, Pathologic
;
Coronary Angiography
;
Disease-Free Survival
;
Follow-Up Studies
;
Heparin
;
Heparin, Low-Molecular-Weight
;
Humans
;
Infarction
;
Myocardial Ischemia
;
Nadroparin*
;
Prospective Studies
;
Stents*
;
Thrombosis
;
Ticlopidine*
6.A Case of Actinic Reticuloid.
Ki Ho KIM ; Sung Moon JUNG ; Min Soo LEE ; Jung Ho YOON ; Jai Il YOUN
Annals of Dermatology 1999;11(4):240-243
Actinic reticuloid as a manifestation of chronic actinic dermatitis (CAD) is a rare dermatosis whose clinical and histologic features resemble other types of pseudolymphomas including mycosis fungoides and Jessner's lymphocytic infiltration, and it is regarded as an eventual stage of various photodermatoses like photosensitive eczema or persistent light reaction or chronic photoallergic contact dermatitis and so on. Phototests in the patients with actinic reticuloid usually reveal hypersensitivity to UVB, UVA, and sometimes to visible light. We present a case of actinic reticuloid in a 65-year-old male, whose skin lesions developed as erythematous lichenified infiltrating plaques on the face at first, and then spread themselves onto the upper trunk later. Histologically those skin lesions showed the aggregation of atypical lymphocytes and photobiologically the results of phototests revealed photosensitivity to UVB and UVA.
Actins*
;
Aged
;
Dermatitis, Photoallergic
;
Eczema
;
Humans
;
Hypersensitivity
;
Light
;
Lymphocytes
;
Male
;
Mycosis Fungoides
;
Photosensitivity Disorders
;
Pseudolymphoma
;
Skin
;
Skin Diseases
7.The treatment of chronic ankle instability.
Seong Bae KIM ; Seung Ki JUNG ; Jae Yo HYUN ; Yul Ho YOON ; Jin Ho MOON
The Journal of the Korean Orthopaedic Association 1991;26(5):1391-1395
No abstract available.
Ankle*
8.Screening of HIV antibody in Korean blood donors.
Young Chul OH ; Ki Hong KIM ; Sang In KIM ; Bum Ryoul CHOI ; Moon Ho LEE
Korean Journal of Blood Transfusion 1992;3(1):55-64
No abstract available.
Blood Donors*
;
HIV*
;
Humans
;
Mass Screening*
9.Two Cases of Osteogenesis Imperfecta Congenita.
Soon Soen LIM ; Byeung Ho LEE ; Young Ha KIM ; Moon Ki JOE
Journal of the Korean Pediatric Society 1988;31(8):1085-1090
No abstract available.
Osteogenesis Imperfecta*
;
Osteogenesis*
10.Clinical study on 44 cases of infant born to polyhydramniotic mother.
Byung Min MOON ; Chun Ho CHO ; Kyoung Sim KIM ; Ki Bok KIM
Journal of the Korean Pediatric Society 1992;35(5):630-638
No abstract available.
Humans
;
Infant*
;
Mothers*
;
Polyhydramnios